Bruker (BRKR) earnings

Earnings (net income) · fiscal 2025
-$8.60M

Bruker (BRKR) reported net income of -$8.60M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was $113.10M. Figures as of 18 Nov 2026, 11:29 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
-$8.60M
Highest on record
$427.20Mfiscal 2023
Lowest on record
-$8.60Mfiscal 2025
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Bruker earnings, in more detail

Across the 17 fiscal years on record (2009–2025), the highest was $427.20M in fiscal 2023 and the lowest -$8.60M in fiscal 2025.

History · 17 fiscal years

Earnings (net income) by fiscal year

Bruker earnings, year by year

Bruker (BRKR) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025-$8.60M 107.6% down
2024$113.10M 73.5% down
2023$427.20M 44.0% up
2022$296.60M 7.0% up
2021$277.10M 75.6% up
2020$157.80M 20.0% down
2019$197.20M 9.7% up
2018$179.70M 128.6% up
2017$78.60M 48.8% down
2016$153.60M 51.2% up
2015$101.60M 79.2% up
2014$56.70M 29.2% down
2013$80.10M 3.4% up
2012$77.50M 16.0% down
2011$92.30M 3.2% down
2010$95.40M 17.8% up
2009$81.00M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Bruker and comparable companies
CompanyEarnings (net income)Fiscal year
Spyre Therapeutics SYRE-$155.20M2025
Qiagen QGEN$424.88M2025
Insulet PODD$247.10M2025
Bruker BRKR-$8.60M2025
Globus Medical GMED$537.87M2025
Madrigal Pharmaceuticals MDGL-$288.28M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BRKR

Bruker, figure by figure

Bruker (BRKR) overview: price, valuation and scorecardAll health care companies by market value

Bruker earnings: questions and answers

What is Bruker's net income?

Bruker (BRKR) reported net income of -$8.60M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was $113.10M.

What are the highest and lowest net income figures on record for Bruker?

Across the 17 fiscal years on record (2009–2025), the highest was $427.20M in fiscal 2023 and the lowest -$8.60M in fiscal 2025.

How is Bruker's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement. For Bruker it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bruker (BRKR) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/BRKR/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.